UVB phototherapeutic modalities. Comparison of two treatments for chronic plaque psoriasis

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 16, Issue 1, 2007, Pages 26-30

  Valkova, Sonya ^a  

^a MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

Author keywords

Bergamot oil; Psoriasis; UVB

Indexed keywords

BERGAMOT OIL; KERATOLYTIC AGENT; PHOTOSENSITIZING AGENT; SALICYLIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRY SKIN; ERYTHEMA; FEMALE; HERPES LABIALIS; HUMAN; HYPERPIGMENTATION; MAJOR CLINICAL STUDY; MALE; PAIN; PHOTOTHERAPY; PRURITUS; PSORIASIS VULGARIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RASH; REMISSION; STATISTICAL ANALYSIS; THERAPY EFFECT; TREATMENT DURATION; ULTRAVIOLET B RADIATION;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PLANT OILS; PSORIASIS; RADIATION DOSAGE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 34247130356     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Barker JN. Psoriasis as a T cell-mediated autoimmune disease. Hosp Med 1998;59:530-3.
2. Van Scott EJ, Ekel TM. Kinetics of hyperplasia in psoriasis. Arch Dermatol 1963;88:373-80.
3. Pittelkow M. Keratinocyte abnormalities. In: Roenigk HH, Maibach HI, editors. Psoriasis. 2nd ed. New York: Marcel Dekker; 1991. p. 305-27.
4. Gottlieb SL, Gilleaudeau P, Johnson R, Estes L, Woodworth TG, Gottlieb AB, et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1995;1:442-7.
5. Asadullah K, Sterry W, Stephanek K, Jasulaitis D, Leupold M, Audring H, et al. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest 1998;101:783-94.
6. Seifert M, Sterry W, Effenberger E, Rexin A, Friedrich M, Haeussler-Quade A, et al. The antipsoriatic activity of IL-10 is rather caused by effects on peripheral blood cells than by a direct effect on human keratinocytes. Arch Dermatol Res 2000;292:164-72.
7. Krueger JG, Wolfe JT, Nabeya RT, Vallat VP, Gilleaudeau P, Heftler NS, et al. Successful UVB treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 1995;182:2057-68.
8. Vallat VP, Gilleaudeau P, Battat L, Wolfe J, Nabeya RT, Heftler NS, et al. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J Exp Med 1994;180:283-96.
9. Ozawa M, Ferenczi K, Kikuchi T, Cardinale I, Aystin LM, Coven TR, et al. 312 nm UVB light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med. 1999;189:711-8.
10. Storbeck K, Holzle E, Schurer N, Lehmann P, Plewig G. Narrow-band UVB (311) versus conventional broad-band UVB with and without dithranol in phototherapy of psoriasis. J Am Acad Dermatol 1993;28(2):227-31.
11. Van Weelden H, Young E, van der Leun JC. Therapy of psoriasis: comparison of photo-chemotherapy and several variations of phototherapy. Br J Dermatol 1980;103:1-9.
12. Koo J. The art of UVB phototherapy for the treatment of psoriasis. In: Weinstein GD, Gottlieb AB, editors. Therapy of moderate-to-severe psoriasis. Stanford: Haber and Flora; 1993. p. 56-74.
13. Weinstein GD, Krueger JG. An overview of psoriasis. In: Weinstein GD, Gottlieb AB, editors. Therapy of moderate-to-severe psoriasis. Stanford: Haber and Flora; 1993. p. 1-22.
14. Wang LH, Tso M. Determination of 5-methoxypsoralen in human serum. J Pharm Biomed Anal 2002;30(3):593-600.
15. Morliere P, Huppe G, Averbeck D, Young AR, Santus R, Dubertret L. In vitro photostability and photosensitizing properties of bergamot oil. Effects of a cinnamate sunscreen. J Photochem Photobiol B 1990;7(2-4):199-208.
16. Fredriksson T, Petterson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
17. Slaper H, Schothorst AA, van der Leun JC. Risk evaluation of UVB therapy for psoriasis: comparison of calculated risk for UVB therapy and observed risk in PUVA patients. Photodermatol 1986;3:271-83.
18. Granstein RD, Matsui MS. UV radiation-induced immunosuppression and skin cancer. Cutis 2004;74(5):4-9.
19. Eells LD, Wolff JM, Carloff J, Eaglstein WH. Comparison of suberythemogenic and maximally aggressive UVB therapy for psoriasis. J Am Acad Dermatol 1984;11:105-10.
20. Petrozzi JW, de los Reyes O. Comparison of once daily and twice daily UV radiation treatments in psoriasis. Arch Dermatol 1981;117:695-7.
21. Stern RS, Armstrong RB, Anderson TF, Bickers DR, Nicholas JL, Harber L et al. Effect of continued UVB phototherapy on the duration of remission of psoriasis: a randomized study. J Am Acad Dermatol 1986;15:546-52.
22. Dogramadjiev D. Photochemotherapy (PUVA) of certain dermatoses Šdissertation, in BulgarianĆ. Sofia: University?; 1986.
23. Diette KM, Momtaz TK, Stern RS, Arndt KA, Parrish JA. Psoralens and UVA and UVB twice weekly for the treatment of psoriasis. Arch Dermatol 1984;120:1169-73.
24. Calzavara-Pinton D. Narrow band UVB (311 nm) phototherapy and PUVA photo-chemotherapy: a combination. J Am Acad Dermatol 1998;38:687-90.
25. Barbagallo J, Spann CT, Tutrone WD, Weinberg JM. Narrowband UVB phototherapy for the treatment of psoriasis: a review and update. Cutis 2001;68(5):345-7.